光環新網(300383.SZ):杭州數字經濟科創中心項目已於2022年11月正式開工
格隆匯5月29日丨有投資者在投資者互動平台向光環新網(300383.SZ)提問,“請問:“計劃在杭州建全國一體化大數據中心長三角國家樞紐節點項目和東數西算示範工程項目,規劃建設10000個6KW的2N標準機櫃,總體投資約32億元,計劃2022年開工建設”的項目,目前是否開工?計劃是否有變?”
公司回覆稱,公司杭州數字經濟科創中心項目已於2022年11月正式開工,該項目是杭州市重點項目,規劃建設10,000個6KW的2N標準機櫃,建成後將為長三角地區用户提供高定製化、高可用性、高安全性的數據中心全生命週期服務及包括公有云、大數據分析、人工智能、物聯網等在內的雲計算平台綜合解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.